Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad + XOI in Gout with Moderate Renal Impairment
NCT03226899Phase 4Terminated
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Jul 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of lesinurad in gout, sponsored by Ironwood Pharmaceuticals. Started Jul 2017; status: terminated.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT03226899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226899.